Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Coronado Biosciences signs agreement with Dr. Falk Pharma and OvaMed

March 26, 2012

Hyperion Therapeutics acquires rights to Ravicti

March 26, 2012

Ablynx extends global strategic Nanobody alliance

March 22, 2012

Shire exercises option to license candidate agent for CNS disorders

March 21, 2012

Cellceutix enters collaboration agreement to support Kevetrin development

March 20, 2012

CUNY to validate diagnostic antibodies

March 20, 2012

QRxPharma and Actavis sign new licensing agreement

March 20, 2012

Merck & Co. enters into collaboration to create new institute

March 20, 2012

Cartagenia enters partnership for rare epilepsy syndromes

March 20, 2012

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...